Page 23 - ARNM-3-1

Advances in Radiotherapy
& Nuclear Medicine Diagnostics gude of biliary tract cancer

doi: 10.1159/000360791 91. De Jong DM, van de Vondervoort S, Dwarkasing RS, et al.
Endoscopic ultrasound in patients with resectable perihilar
80. Cowling MG, Adam AN. Internal stenting in malignant
biliary obstruction. World J Surg. 2001;25(3):355-359; cholangiocarcinoma: Impact on clinical decision-making.
discussion 359-361. Endosc Int Open. 2023;11(2):E162-E168.
doi: 10.1007/s002680020384 doi: 10.1055/a-2005-3679
81. Rizvi S, Eaton J, Yang JD, Chandrasekhara V, Gores GJ. 92. Nguyen K, Sing JT Jr. Review of endoscopic techniques in
Emerging technologies for the diagnosis of perihilar the diagnosis and management of cholangiocarcinoma.
cholangiocarcinoma. Semin Liver Dis. 2018;38(2):160-169. World J Gastroenterol. 2008;14(19):2995-2999.
doi: 10.1055/s-0038-1655775 doi: 10.3748/wjg.14.2995
82. Kalaitzakis E, Levy M, Kamisawa T, et al. Endoscopic 93. Büsing KA, Schönberg SO, Brade J, Wasser K. Impact of
retrograde cholangiography does not reliably distinguish blood glucose, diabetes, insulin, and obesity on standardized
IgG4-associated cholangitis from primary sclerosing uptake values in tumors and healthy organs on 18F-FDG
cholangitis or cholangiocarcinoma. Clin Gastroenterol PET/CT. Nucl Med Biol. 2013;40(2):206-213.
Hepatol. 2011;9(9):800-803.e2. doi: 10.1016/j.nucmedbio.2012.10.014
doi: 10.1016/j.cgh.2011.05.019 94. Annunziata S, Caldarella C, Pizzuto DA, et al. Diagnostic
83. Chaves, J., Fernandez, Y., Viesca, M., Arvanitakis, M. Using accuracy of fluorine-18-fluorodeoxyglucose positron
Endoscopy in the Diagnosis of Pancreato-Biliary Cancers. emission tomography in the evaluation of the primary
Cancers (Basel). 2023 Jun 28;15(13):3385. tumor in patients with cholangiocarcinoma: A meta-
analysis. Biomed Res Int. 2014;2014:247693.
84. Jo JH, Cho CM, Jun JH, et al. Same-session endoscopic
ultrasound-guided fine needle aspiration and endoscopic doi: 10.1155/2014/247693
retrograde cholangiopancreatography-based tissue sampling 95. Anderson CD, Rice MH, Pinson CW, Chapman WC,
in suspected malignant biliary obstruction: A multicenter Chari RS, Delbeke D. Fluorodeoxyglucose PET imaging in the
experience. J Gastroenterol Hepatol. 2019;34(4):799-805. evaluation of gallbladder carcinoma and cholangiocarcinoma.
doi: 10.1111/jgh.14528 J Gastrointest Surg. 2004;8(1):90-97.
85. Levy MJ, Heimbach JK, Gores GJ. Endoscopic ultrasound doi: 10.1016/j.gassur.2003.10.003
staging of cholangiocarcinoma. Curr Opin Gastroenterol. 96. Kim JY, Kim MH, Lee TY, et al. Clinical role of 18F-FDG PET-CT
2012;28(3):244-252. in suspected and potentially operable cholangiocarcinoma:
doi: 10.1097/MOG.0b013e32835005bc A prospective study compared with conventional imaging. Am
J Gastroenterol. 2008;103(5):1145-1151.
86. Strongin A, Singh H, Eloubeidi MA, Siddiqui AA. Role of
endoscopic ultrasonography in the evaluation of extrahepatic doi: 10.1111/j.1572-0241.2007.01710.x
cholangiocarcinoma. Endosc Ultrasound. 2013;2(2):71-76. 97. Breitenstein S, Apestegui C, Clavien PA. Positron emission
doi: 10.4103/2303-9027.117690 tomography (PET) for cholangiocarcinoma. HPB (Oxford).
2008;10(2):120-121.
87. Orzan RI, Pojoga C, Agoston R, Seicean R, Seicean A.
Endoscopic ultrasound in the diagnosis of extrahepatic doi: 10.1080/13651820801992583
cholangiocarcinoma: What do we know in 2023? Diagnostics 98. Lee Y, Yoo IR, Boo SH, Kim H, Park HL, Hyun OJ. The role
(Basel). 2023;13(6):1023. of F-18 FDG PET/CT in intrahepatic cholangiocarcinoma.
doi: 10.3390/diagnostics13061023 Nucl Med Mol Imaging. 2017;51(1):69-78.
88. Onda S, Ogura T, Kurisu Y, et al. EUS-guided FNA for doi: 10.1007/s13139-016-0440-y
biliary disease as first-line modality to obtain histological 99. Fiz F, Masci C, Costa G, et al. PET/CT-based radiomics of
evidence. Therap Adv Gastroenterol. 2016;9(3):302-312. mass-forming intrahepatic cholangiocarcinoma improves
doi: 10.1177/1756283X15625584 prediction of pathology data and survival. Eur J Nucl Med
Mol Imaging. 2022;49(10):3387-3400.
89. Shin DW, Moon SH, Kim JH. Diagnosis of
cholangiocarcinoma. Diagnostics (Basel). 2023;13(2):233. doi: 10.1007/s00259-022-05765-1
doi: 10.3390/diagnostics13020233 100. Jiang L, Tan H, Panje CM, Yu H, Xiu Y, Shi H. Role of 18F-
FDG PET/CT imaging in intrahepatic cholangiocarcinoma.
90. Harewood GC. Endoscopic tissue diagnosis of
cholangiocarcinoma. Curr Opin Gastroenterol. 2008; Clin Nucl Med. 2016;41(1):1-7.
24(5):627-630. doi: 10.1097/RLU.0000000000000998
doi: 10.1097/MOG.0b013e32830bf7e1 101. Guniganti P, Kierans AS. PET/MRI of the hepatobiliary

Volume 3 Issue 1 (2025) 15 doi: 10.36922/arnm.4557